deltatrials
Completed NA INTERVENTIONAL 2-arm NCT01736644

Bipolar Sealer Aquamantys Use in Total Knee Replacement

A Prospective Randomized Control Trial to Compare the Aquamantys System With Standard Electrocautery in Reducing Blood Loss in Primary Total Knee Arthroplasty

Sponsor: Medtronic Surgical Technologies

Conditions Arthritis Disability Hemorrhage Infection Inflammation Osteoarthritis Surgery
Interventions Bipolar sealer Aquamantys Electrocautery
Updated 6 times since 2017 Last updated: Feb 25, 2020 Started: Oct 31, 2012 Primary completion: Oct 27, 2013 Completion: Oct 27, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Arthritis and Disability, this trial is completed. The trial is conducted by Medtronic Surgical Technologies and has accumulated 6 data snapshots since 2012. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Mar 2020 · 21 months · monthly snapshotUnknown Status~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Mar 2020 — Jan 2021 [monthly]

    Completed NA

    Status: Unknown Status → Completed · Phase: PHASE4 → NA

  5. Jun 2018 — Mar 2020 [monthly]

    Unknown Status PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE4

    First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Medtronic Surgical Technologies
Data source: Medtronic Surgical Technologies

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations